| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9328408 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
Amplification of the HER2/neu oncogene represents a common finding in USPC. FISH analysis should be used for confirmation of gene amplification in USPC showing 2+ expression of HER2/neu. Prior screening and selection of appropriate immunohistochemistry-positive areas may be beneficial in the selection of some USPC patients undergoing FISH analysis.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Alessandro D. Santin, Stefania Bellone, Sue Van Stedum, Wendy Bushen, Luis E. De Las Casas, Soheila Korourian, Erming Tian, Juan J. Roman, Alexander Burnett, Sergio Pecorelli,